Renal outcomes in metformin users versus non-metformin users in veterans with type 2 diabetes mellitus (T2DM).

被引：0
|
作者：
Gosmanova, E.
Canada, R. B.
Mangold, T. A.
Rawls, W. N.
Wall, B. M.
机构：
[1] VAMC, Memphis, TN USA
[2] Univ Texas, Hlth Sci Ctr, Memphis, TN USA
来源：
AMERICAN JOURNAL OF KIDNEY DISEASES | 2007年 / 49卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
70
引用
收藏
页码：A42 / A42
页数：1
相关论文
共 50 条
  • [41] Vascular responsiveness in type 2 diabetes mellitus (T2DM)
    Blum, A.
    Socea, D.
    Sirchan, R.
    QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2016, 109 (12) : 791 - 796
  • [42] The platelets characteristics in type 2 diabetes mellitus (T2DM)
    Buryachkovskaya, L.
    Uchitel, I. A.
    Sumarokov, A. B.
    Docenko, U., V
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 931 - 931
  • [43] Microvascular complications in type 2 diabetes mellitus (T2DM).
    Cheung, AT
    Ramanujam, S
    Duong, PL
    Schauer, D
    Chan, LS
    Dwyre, DM
    Larkin, EC
    FASEB JOURNAL, 2002, 16 (04): : A208 - A208
  • [44] Association between Hypoglycemia and Medication Adherence among Veterans With Type 2 Diabetes Mellitus (T2DM)
    Zhao, Yingnan
    Campbell, Claudia
    Fonseca, Vivian
    Shi, Lizheng
    DIABETES, 2012, 61 : A553 - A553
  • [45] Once Weekly Dulaglutide Enhances β-Cell Function Compared to Metformin in Patients with Type 2 Diabetes (T2DM)
    Mari, Andrea
    Del Prato, Stefano
    Ludvik, Bernhard
    de la Pena, Amparo
    Shurzinske, Linda
    Pechtner, Valeria
    ENDOCRINE REVIEWS, 2014, 35 (03)
  • [46] COST-EFFECTIVENESS OF CANAGLIFLOZIN (CANA) VERSUS SITAGLIPTIN (SITA) AS ADD-ON TO METFORMIN PLUS SULFONYLUREA IN PATIENTS WITH TYPE 2 DIABETES MELLITUS (T2DM) IN BRAZIL
    Pititto, L.
    Neslusan, C.
    Teschemaker, A. R.
    Johansen, P.
    Willis, M.
    Asano, E.
    Puig, A.
    VALUE IN HEALTH, 2015, 18 (07) : A864 - A864
  • [47] THE COST-EFFECTIVENESS OF CANAGLIFLOZIN VERSUS INSULIN-SECRETAGOGUES (SULPHONYLUREAS) OR INSULIN IN PATIENTS WITH TYPE 2 DIABETES MELLITUS (T2DM) AS AN ADD-ON TO METFORMIN IN IRELAND
    Bacon, T.
    Willis, M.
    Johansen, P.
    Neslusan, C.
    Nuhoho, S.
    Worbes-Cerezo, M.
    VALUE IN HEALTH, 2014, 17 (07) : A346 - A346
  • [48] Efficacy and Safety of Canagliflozin (CANA) in Subjects With Type 2 Diabetes Mellitus (T2DM) on Metformin (MET) and Pioglitazone (PIO) Over 52 Weeks
    Forst, Thomas
    Guthrie, Robert
    Goldenberg, Ronald
    Yee, Jacqueline
    Vijapurkar, Ujjwala
    Meininger, Gary
    Stein, Peter
    DIABETES, 2013, 62 : A284 - A284
  • [49] Saxagliptin vs Glipizide as Add-On Therapy to Metformin for Type 2 Diabetes Mellitus (T2DM): Long-Term Safety and Efficacy
    Goeke, Burkhard
    Gallwitz, Baptist
    Eriksson, Johan
    Bokelund-Singh, Sara
    Gause-Nilsson, Ingrid
    DIABETES, 2011, 60 : A305 - A305
  • [50] The effect of metformin on autophagy by LC3 expression in Type 2 Diabetes Mellitus (T2DM) human skeletal muscle cell culture
    Prajitno, Jongky Hendro
    Pranoto, Agung
    Adiwinoto, Robert Dwitama
    Soelistijo, Soebagijo Adi
    BALI MEDICAL JOURNAL, 2022, 11 (01) : 349 - 355
12345